Delivery Order SPE2DB22D1002-SPE2DB23FLAP5
Award Date
5/8/23
Potential Completion Date
5/9/23
Potential Value
$1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,742.98 firm fixed-price delivery order is for the supply of 4,566,975,174 units of OSELTAMIVIR PHOS 75 MG CAPSULE UD 10S, with a completion date of January 21, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,689.90, is a Firm Fixed Price Delivery Order for the supply of 4567103940 - OSELTAMIVIR PHOS 75 MG CAPSULE UD 10S. The ultimate completion date for this contract is January 31, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is for the delivery of OSELTAMIVIR PHOS 75 MG CAPSULE UD 10S to the Defense Logistics Agency (DLA). The $16,028.80 firm-fixed-price delivery order has an ultimate completion date of August 28, 2023. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The $1,038.48 contract is for the provision of OSELTAMIVIR PHOS 75 MG CAPSULE UD 10S, a type of antiviral medication. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00, which serves as the primary vehicle for Amerisourcebergen to deliver...
This federal contract award, identified as SPE2DB22D2206|SPE2DB25FFJ41, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,290.35, is for the delivery of OSELTAMIVIR PHOS 75 MG CAPSULE UD 10S, a pharmaceutical product. The award is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at...
This federal contract award SPE2DB20D1109|SPE2DB24FP88L, valued at $1,901.46, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of 4565751140 - OSELTAMIVIR PHOS 75 MG CAPSULE UD 10S, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of September 11, 2024. This award is not designated as a set-aside contract. Amerisourcebergen Drug...
This federal contract award, identified as SPE2DB20D3103|SPE2DB24FP4R7, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,726.68, is a delivery order for the supply of 4565097631 - OSELTAMIVIR PHOS 75 MG CAPSULE UD 10S. The contract is a Firm Fixed Price arrangement, with a completion date of July 10, 2024. Amerisourcebergen Drug Corp, a...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The contract is for the delivery of OSELTAMIVIR PHOS 75 MG CAPSULE UD 10S, a pharmaceutical product, with a potential value of $5,531.57. The contract has a completion date of December 21, 2023 and was awarded on December 20, 2023. No set-aside designation was used for this award. AmerisourceBergen Drug Corp, through its...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Oseltamivir Phosphate 75 mg capsules. The contract has a total ceiling value of $1,328.80 and an ultimate completion date of January 7, 2025. It is a firm-fixed-price delivery order contract, with no set-aside designation. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Oseltamivir Phosphate 75 mg capsules. The contract has a ceiling value of $1,594.56 and a final completion date of February 4, 2025. It is a firm-fixed-price contract, with no set-aside designation. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...